cancer drug prices rise 53% in five years -report ( Reuters) Updated: Eli Lilly blames Biden's IRA for cancer drug discontinuation as the new pharma playbook takes shape ( Endpoints).New JAMA study digs into the rise of stacking FDA’s expedited programs and designations for new drugs ( Endpoints).
0 Comments
Leave a Reply. |